Amarin Corporation
AMRN
#8021
Rank
A$0.43 B
Marketcap
A$20.91
Share price
0.34%
Change (1 day)
41.48%
Change (1 year)

Earnings for Amarin Corporation (AMRN)

Earnings in 2025 (TTM): -A$0.14 Billion

According to Amarin Corporation 's latest financial reports the company's current earnings are A$0.22 Billion. In 2024 the company made an earning of -A$0.11 Billion a decrease over its 2023 earnings that were of -A$75.95 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Amarin Corporation from 1994 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.14 Billion23.39%
2024 -A$0.11 Billion43.84%
2023 -A$75.95 Million-48.3%
2022 -A$0.15 Billion-1019.36%
2021 A$15.97 M-165.44%
2020 -A$24.42 Million-23.25%
2019 -A$31.82 Million-80.68%
2018 -A$0.17 Billion112.25%
2017 -A$77.58 Million-28.23%
2016 -A$0.11 Billion-35.43%
2015 -A$0.17 Billion99.81%
2014 -A$83.78 Million-65.06%
2013 -A$0.24 Billion-0.38%
2012 -A$0.25 Billion-150.87%
2011 A$0.47 B-233.68%
2010 -A$0.36 Billion
2007 -A$55.24 Million44.04%
2006 -A$38.35 Million
2004 -A$20.73 Million-46.41%
2003 -A$38.67 Million-41.09%
2002 -A$65.63 Million813.31%
2001 -A$7.19 Million113.63%
2000 -A$3.37 Million
1998 -A$23.92 Million98.82%
1997 -A$12.03 Million-50.29%
1996 -A$24.2 Million-1321.43%
1995 A$1.98 M-94.53%
1994 A$36.22 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
AbbVie
ABBV
A$9.33 B-7,851.87%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$19.96 B-16,677.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$14.00 B-11,728.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
Alkermes
ALKS
A$0.42 B-456.90%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Teva Pharmaceutical Industries
TEVA
A$3.04 B-2,628.73%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel